Subtitle
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and Bulky Tumor Management.
Subtitle
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and Bulky Tumor Management.
Proto therapy Time
June 2024
Executive summary
This review presents consensus guidelines for adoption and practice of GRID and Lattice RT, as well as detailed guidance for dosimetry and treatment planning of GRID and Lattice in treating radioresistant and bulky tumors, including soft tissue sarcomas, osteosarcomas, renal cell carcinoma, melanoma, gastrointestinal stromal tumors (GISTs), pancreatic cancer, glioblastoma, and hepatocellular carcinoma.
Top cancer treatments
Related contents
Proton Therapy Publication
September 2024
Cost-utility analysis of proton beam therapy for locally advanced esophageal cancer in Japan.
Proton Therapy Publication
September 2024
Particle therapy in gastrointestinal cancer-a narrative review.
Proton Therapy Publication
September 2024
Clinical Outcomes of Proton Beam Therapy for Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Retrospective Study.
Proton Therapy Publication
June 2024
Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis.
Proton Therapy Publication
May 2024
PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement.
Proton Therapy Publication
May 2024
Comparing 90-Day Postoperative Mortality After Neoadjuvant Proton-Based Versus Photon-Based Chemoradiotherapy for Esophageal Cancer.
Proton Therapy Publication
May 2024
Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma.
Proton Therapy Publication
May 2024
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
Proton Therapy Publication
May 2024
Proton Beam Therapy for Treating Patients with Hepatocellular Carcinoma with Major Portal Vein Tumor Invasion: A Single Center Retrospective Study.